The Travelers Companies, Inc. (NYSE: TRV) announced Tuesday that it expects $1.7 billion in pretax catastrophe losses from the California wildfires that swept through the state in January. After taxes, the estimated loss amounts to $1.3 billion. read more
Cryptocurrency markets are trading lower on Tuesday, with Bitcoin tapping the $95,000 level. read more
Regenxbio’s gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and declining appeal in retinal diseases. Latest Ratings for RGNX Date Firm Action From To Mar 2022 SVB Leerink Maintains Market Perform Feb 2022 SVB Leerink Maintains Market Perform Jan 2022 SVB Leerink Maintains Market Perform View More…
Elon Musk caused a stir in the crypto world by changing his profile name to Harry Bōlz, sparking a $20 million valuation for the HARRYBOLZ token. read more
Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand. Latest Ratings for DVAX Date Firm Action From To Dec 2021 HC Wainwright & Co. Maintains Buy Aug 2021 HC Wainwright & Co. Maintains Buy Aug 2021 Goldman Sachs Initiates Coverage On Buy View…
Goldman Sachs analyst maintains Buy on Alibaba Group with $117 price target. Notes strong performance in Qwen2.5 model and potential for cloud growth. Latest Ratings for BABA Date Firm Action From To Feb 2022 Barclays Maintains Overweight Feb 2022 Stifel Maintains Buy Feb 2022 Citigroup Maintains Buy View More Analyst Ratings for BABA View the…
Latest Ratings for GAMB Date Firm Action From To Aug 2021 Truist Securities Initiates Coverage On Buy Aug 2021 Jefferies Initiates Coverage On Buy View More Analyst Ratings for GAMB View the Latest Analyst Ratings read more
Latest Ratings for IRT Date Firm Action From To Jan 2022 Barclays Initiates Coverage On Overweight Jan 2022 Compass Point Upgrades Neutral Buy Jan 2022 RBC Capital Initiates Coverage On Outperform View More Analyst Ratings for IRT View the Latest Analyst Ratings read more